These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24423299)

  • 41. Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform.
    Chan SL; Rana S; Chinthala S; Salahuddin S; Yeo KJ
    Pregnancy Hypertens; 2018 Jan; 11():66-70. PubMed ID: 29523276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenic factors and preeclampsia.
    Tjoa ML; Levine RJ; Karumanchi SA
    Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.
    Denney JM; Bird C; Gendron-Fitzpatrick A; Sampene E; Bird IM; Shah DM
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F445-F455. PubMed ID: 27927648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
    Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
    J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.
    Koga K; Osuga Y; Tajima T; Hirota Y; Igarashi T; Fujii T; Yano T; Taketani Y
    Fertil Steril; 2010 Jun; 94(1):305-8. PubMed ID: 19269632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble Flt1 levels are associated with cardiac dysfunction in Black women with and without severe preeclampsia.
    Levine L; Arany Z; Kern-Goldberger A; Koelper N; Lewey J; Sammel MD; Elovitz MA; Ky B
    Hypertens Pregnancy; 2021 Feb; 40(1):44-49. PubMed ID: 33345653
    [No Abstract]   [Full Text] [Related]  

  • 48. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling.
    Drewlo S; Levytska K; Sobel M; Baczyk D; Lye SJ; Kingdom JC
    J Thromb Haemost; 2011 Dec; 9(12):2486-97. PubMed ID: 21981655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.
    Rajakumar A; Cerdeira AS; Rana S; Zsengeller Z; Edmunds L; Jeyabalan A; Hubel CA; Stillman IE; Parikh SM; Karumanchi SA
    Hypertension; 2012 Feb; 59(2):256-64. PubMed ID: 22215706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1).
    Jiang X; Bar HY; Yan J; Jones S; Brannon PM; West AA; Perry CA; Ganti A; Pressman E; Devapatla S; Vermeylen F; Wells MT; Caudill MA
    FASEB J; 2013 Mar; 27(3):1245-53. PubMed ID: 23195033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy.
    Perni U; Sison C; Sharma V; Helseth G; Hawfield A; Suthanthiran M; August P
    Hypertension; 2012 Mar; 59(3):740-6. PubMed ID: 22311907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia.
    Suresh S; Mueller A; Salahuddin S; Naseem H; Dhir R; Rana S
    Pregnancy Hypertens; 2020 Jul; 21():124-131. PubMed ID: 32505096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Unversucht A; Wessel N; Faber R
    Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
    Woodham PC; Brittain JE; Baker AM; Long DL; Haeri S; Camargo CA; Boggess KA; Stuebe AM
    Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.
    Burke SD; Zsengellér ZK; Khankin EV; Lo AS; Rajakumar A; DuPont JJ; McCurley A; Moss ME; Zhang D; Clark CD; Wang A; Seely EW; Kang PM; Stillman IE; Jaffe IZ; Karumanchi SA
    J Clin Invest; 2016 Jul; 126(7):2561-74. PubMed ID: 27270170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
    Baltajian K; Hecht JL; Wenger JB; Salahuddin S; Verlohren S; Perschel FH; Zsengeller ZK; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2014 Nov; 33(4):427-39. PubMed ID: 25062083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.
    Lopes Perdigao J; Chinthala S; Mueller A; Minhas R; Ramadan H; Nasim R; Naseem H; Young D; Shahul S; Chan SL; Yeo KJ; Rana S
    Hypertension; 2019 Apr; 73(4):868-877. PubMed ID: 30798660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy.
    Rosenberg VA; Buhimschi IA; Lockwood CJ; Paidas MJ; Dulay AT; Ramma W; Abdel-Razeq SS; Zhao G; Ahmad S; Ahmed A; Buhimschi CS
    Circulation; 2011 Dec; 124(23):2543-53. PubMed ID: 22082677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.